Tech4Eva

Deadline: As soon as possible

Events

Trainings & Fellowships Grant Tech & IT

Location(s)

  • Online

Overview

A new chapter for women's health innovation. For five years, the Tech4Eva initiative has explored what it takes to bring femtech innovation into healthcare. Today, we are taking that experience into a new, independent chapter.

Details

WHAT'S NEXT

Implementation.

Validation.

Impact.

The next chapter of Tech4Eva is built on a simple conviction: real impact in women's health requires more than great ideas — it requires clinical proof, operational readiness, and investor-grade validation.

We are designing the next chapter around these principles. Stay connected — the announcement is coming soon.

  • Clinical-grade validation: We will work with startups that have demonstrated real-world implementation in a clinical or operational setting.
  • Tech4Eva Impact Score: A proprietary scoring framework, in design, to benchmark Femtech solutions across health economics, operational acceptance, and scalability.
  • Curated investor access: We will connect validated startups with a global network of family offices, VCs, and strategic partners focused on women's health.

Opportunity is About


Eligibility

Candidates should be from:


Description of Ideal Candidate

The Tech4Eva Impact Score

We are designing a rigorous, standardised framework to evaluate Femtech solutions beyond the pitch deck. The Tech4Eva Impact Score will assess every startup across three critical axes — designed to give investors the confidence they need, and startups the validation they deserve.

01. Health Economics

Does the solution generate measurable economic value for the healthcare system? We will quantify cost savings, return on investment, and long-term impact on chronic disease prevention — the language investors and payers speak.

  • ROI
  • COST PER OUTCOME
  • PAYER READINESS

02. Operational Acceptance

Is the solution actually used — by patients and by healthcare professionals? We will measure real-world adoption, retention, and the reduction of clinical workload, because a solution that isn't used creates no value.

  • RETENTION
  • CLINICAL ADOPTION
  • USER ENGAGEMENT

03. Scalability

Can the solution grow without proportionally growing its costs or complexity? We will evaluate operational autonomy, technology readiness, and the ability to expand across geographies and health systems.

  • TECH MATURITY
  • OPERATIONAL AUTONOMY
  • MARKET READINESS

Dates

Deadline: As soon as possible


Cost/funding for participants

+ More Info / Application Save Opportunity Un-save Opportunity


find-dream
Search from 1718 opportunities in 164 countries

Internships, scholarships, student conferences and competitions.